Beate Sander

PhD (University of Toronto)
MEcDev (Australian National University, Australia)
MBA (Technische Universität Bergakademie Freiberg,Germany)
RN (Medizinische Fachschule Chemnitz, Germany)

Professional Interests

economic evaluation of health care interventions with a focus on public health, decision analysis, health economics, mathematical modeling, use of laboratory, surveillance, and administrative data for economic evaluation, public health, vaccine-preventable diseases


1) Our 2010 paper entitled ” The Cost-Effectiveness of Ontario’s Universal Influenza Immunization Program” presented the first study to provide evidence that a universal program is economically attractive in jurisdictions with influenza epidemiology and health care costs broadly similar to Ontario. This study has supported health policy decisions in many jurisdictions considering the implementation of universal immunization in Canada and elsewhere. As of the 2013/2014 influenza season, a publicly funded universal influenza immunization program is available in eight Canadian jurisdictions and the US CDC’s ACIP cites this study among others in support of recommending influenza immunization “to all persons aged ≥6 months”.

2) In the study entitled “Is a Mass Immunization Program for Pandemic (H1N1) 2009 Good Value for Money? Evidence from the Canadian Experience.” we assessed the cost-effectiveness of Ontario’s H1N1 mass immunization program, concluding that Ontario’s pandemic H1N1 immunization program was cost-effective as implemented. However, the results also strongly suggested that additional delays would have eroded the program’s cost-effectiveness considerably. This was the first evaluation of a mass immunization program implemented in response to H1N1, generating much public discussion in Ontario.

3) Internationally, I am an active member of the Society for Medical Decision Making (SMDM). I was elected to serve a three-year term on the board of SMDM as a trustee. As part of my commitment to engage fellow decision analysts and health economists on methods in infectious disease modeling and facilitate knowledge exchange I have set up and am co-leading SMDM’s interest group in infectious disease modeling.

Other Affiliations

  • Scientist and Director of Population Health Economics Research, Toronto Health Economics and Technology Assessment Collaborative (THETA)

 Awards/Distinctions (last 5 years)

2012- Thomas and Edna Naylor Memorial Award (Best Paper based on Thesis in Health Services and Health Care Research). $1,000; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada

2010- Lee B. Lusted Student Prize (outstanding presentation of research). $500; Society for Medical Decision Making (SMDM), 31th Annual Meeting, Toronto, ON, Canada

2010- Sanofi Pasteur Award for Communicable Disease Epidemiology (awarded to the two highest ranked abstracts submitted to ISID’s International Congress on Infectious Diseases). $2,500; International Society for Infectious Diseases (ISID), 14th International Congress on Infectious Diseases, Miami, FL, USA

Current Grants as PI

Reducing the burden of hospital-associated Clostridium Difficile infections in Canada through optimal prevention policies: A multidisciplinary individual-based modeling approach.; (10/2014-09/2018) Marc Brisson (nominated PI), Beate Sander (co-PI); Canadian Institutes for Health Research, Operating Grant, $475,367

The cost-effectiveness of West Nile virus intervention strategies. A computer simulation model.; (04/2014-03/2017) Beate Sander (nominated PI), Huaiping Zhu (co-PI); Canadian Institutes for Health Research, Operating Grant, $450,000

Estimating longitudinal healthcare cost for infectious diseases using administrative data.; (10/2013-09/2016) Beate Sander (nominated PI), Jeff Kwong (co-PI); Canadian Institutes for Health Research, Operating Grant, $474,627

Assessing the health and economic burden of Lyme disease using laboratory and health administrative data.; (04/2014-03/2015) Beate Sander (nominated PI), Samir Patel (co-PI); Public Health Ontario, Project Grant, $99,000

Assessing the health and economic burden of mycobacterial infections using laboratory and health administrative data.; (06/2013-03/2015) Beate Sander (nominated PI), Francis Jamieson (co-PI); Public Health Ontario, Project Grant, $45,000

The Cost-Effectiveness of Integrated Cervical Cancer Prevention Strategies in Ontario; (04/2014-06/2014) William Wong (nominated PI), Beate Sander (co-PI); Canadian Partnership Against Cancer Case Study Evaluation, $15,000



Additional Recent Publications

Quach S, Pereira JA, Heidebrecht CL, Kwong JC, Guay M, Crowe L, Quan S, Bettinger JA; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Vaccine Coverage Theme Group (Brien S, Buckeridge D, Chambers L, Hamid J, Crowcroft N, Deeks S, Finkelstein M, Bettinger J, Guay M, Kalailieff D, Crowe L, Heidebrecht C, Kolbe F, Kwong J, McGeer A, Winter AL, Nassif J, Pereira J, Quach S, Quan S, Sander B, Sikora C.). Health care worker influenza immunization rates: the missing pieces of the puzzle. Am J Infect Control. 2013; 41(8):685-90.

Wormsbecker A, Sander B, Deeks S. Herpes zoster vaccine: Options for consideration. Ontario Agency for Health Protection and Promotion. 2013.

Ontario Agency for Health Protection and Promotion (Public Health Ontario). Obesity in Children and Youth: Evidence and Action. 2013. [Contributor]

Cancer Care Ontario, Ontario Agency for Health Protection and Promotion (Public Health Ontario). Taking action to prevent chronic disease: recommendations for a healthier Ontario. Toronto: Queen’s Printer for Ontario; 2012. [Contributor]